SLN

Conviction 100HealthcareScan · Mon, Aug 10, 2026

SLN$15.38+28.70%

ResistanceSupportVol 14Insider sell

Vol MA14 996.91K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Silence Therapeutics plcPHARMACEUTICAL PREPARATIONSwww.silence-therapeutics.com ↗

Price15.38

Change+28.70%

Gap+38.33%

Rel volume12.54×

Avg volume822.79K

Avg $ vol10.56M

SMA 2011.33

SMA 509.41

SMA 2007.01

Price vs 50+63.41%

Price vs 200+119.43%

MA stackbullish

50/200 cross—

Supertrendup · 12.14

RSI (14)77

MACD hist0.18

MACD crossbull · 0d

Stoch %K / %D70 / 77

ADX (14)37

+DI / −DI48 / 8

RSI divergenceBearish

MACD divergence—

ATR %+7.65%

ADR %8.56%

52w high15.38

52w low4.30

From 52w high+0.00%

Above 52w low+257.67%

New 52w highYes

SqueezeOff

Bollinger width38.86%

%B1.42

Donchian pos75.23%

Donchian high17.51

Donchian low8.91

AVWAP (52w high)15.85

vs AVWAP high-2.97%

AVWAP (52w low)9.11

vs AVWAP low+68.79%

OBV trendUp

Chaikin MF (20)-0.03

Today vs 20d12.54×

Avg vol (14d)996.91K

Avg vol (20d)822.79K

Avg $ vol (20d)10.56M

Market cap—

RS 3m (vs SPY)+66.25%

RS 6m (vs SPY)+150.27%

RS line new highNo

Trend template8/8

Technical rank98.1

1 week+44.01%

1 month+69.20%

3 months+120.66%

6 months+223.79%

1 year+185.87%

YTD+150.08%

P/E-19.09

P/B34.25

P/S—

P/FCF-27.15

EPS-0.6300

Div yield—

ROE-179.37%

ROA-76.97%

Debt/Eq—

Current9.83

EV/EBITDA—

Gross margin61.54%

Net margin—

Rev growth-98.71%

EPS growth-95.57%

Price target34.67

Target upside190.37%

Analyst ratingBuy

Institutional13.38%

Ent. value1.69B

Revenue422K

Net income-14.96M

Gross profit411K

Free cash flow-62.33M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out47.23M

Employees88

ListedTue, Sep 8, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank98.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance12.05

Support7.72

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLN

All disclosures →

No recent disclosed trades by Congress in SLN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLN · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Griffiths Richard Ian 10% owner · American Depositary Shares · 2026-07-06	Sell	865.11K	—	2026-07-06	2026-07-07
Griffiths Richard Ian 10% owner · American Depositary Shares · 2026-07-02	Sell	50.08K	—	2026-07-02	2026-07-07
Griffiths Richard Ian 10% owner · American Depositary Shares · 2026-07-01	Sell	79.18K	—	2026-07-01	2026-07-07
Griffiths Richard Ian 10% owner · American Depositary Shares · 2026-07-01	Sell	50K	—	2026-07-01	2026-07-07
Griffiths Richard Ian 10% owner · American Depositary Shares · 2026-06-30	Sell	169.93K	—	2026-06-30	2026-07-07
Griffiths Richard Ian 10% owner · American Depositary Shares · 2026-06-29	Sell	330.07K	—	2026-06-29	2026-07-07

SEC filings

EDGAR filings in SLN · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.